US Patent 11859012 Heterodimeric antibodies that bind CD3 and GPC3
Patent 11859012 was granted and assigned to Xencor on January, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 3 Jan, 2024
Golden AI
Edits made to:
Infobox (+52 properties)
Article (+248 characters)
US Patent 11859012 Heterodimeric antibodies that bind CD3 and GPC3
Article
Patent abstract
Provided herein are novel GPC3 binding domains, and antibodies that include such GPC3 binding domains (e.g., anti-GPC3×anti-CD3). Also provided herein are methods of using such antibodies for the treatment of GPC3-associated cancers.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Alex Nisthal0
Katrina Bykova0
Matthew J. Bernett0
Nargess Hassanzadeh-Kiabi0
Rajat Varma0
Date of Patent
January 2, 2024
0Patent Application Number
176920450
Date Filed
March 10, 2022
0Patent Citations
Patent Primary Examiner
CPC Code
Find more entities like US Patent 11859012 Heterodimeric antibodies that bind CD3 and GPC3
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
